ATE317257T1 - Verwendung von estern von l-carnitinsäure oder von alkanoyl l-carnitinsäure als kationische lipide für die intrazelluläre verabreichung therapeutischer stoffe - Google Patents
Verwendung von estern von l-carnitinsäure oder von alkanoyl l-carnitinsäure als kationische lipide für die intrazelluläre verabreichung therapeutischer stoffeInfo
- Publication number
- ATE317257T1 ATE317257T1 AT03020049T AT03020049T ATE317257T1 AT E317257 T1 ATE317257 T1 AT E317257T1 AT 03020049 T AT03020049 T AT 03020049T AT 03020049 T AT03020049 T AT 03020049T AT E317257 T1 ATE317257 T1 AT E317257T1
- Authority
- AT
- Austria
- Prior art keywords
- carnitic
- alkanoyl
- esters
- acid
- carnitic acid
- Prior art date
Links
- 230000003834 intracellular effect Effects 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 2
- 150000002632 lipids Chemical class 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
- -1 alkanoyl L-carnitines Chemical class 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999RM000220A IT1306129B1 (it) | 1999-04-13 | 1999-04-13 | Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE317257T1 true ATE317257T1 (de) | 2006-02-15 |
Family
ID=11406659
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03020049T ATE317257T1 (de) | 1999-04-13 | 2000-04-11 | Verwendung von estern von l-carnitinsäure oder von alkanoyl l-carnitinsäure als kationische lipide für die intrazelluläre verabreichung therapeutischer stoffe |
AT00922852T ATE286873T1 (de) | 1999-04-13 | 2000-04-11 | Ester des l-carnitin oder alkanoyl l-carnitin zur verwendung als kationische lipide für die intrazelluläre verabreichung therapeutischer stoffe |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00922852T ATE286873T1 (de) | 1999-04-13 | 2000-04-11 | Ester des l-carnitin oder alkanoyl l-carnitin zur verwendung als kationische lipide für die intrazelluläre verabreichung therapeutischer stoffe |
Country Status (34)
Country | Link |
---|---|
US (4) | US6797281B1 (de) |
EP (3) | EP1435232A1 (de) |
JP (2) | JP4703855B2 (de) |
KR (2) | KR100798499B1 (de) |
CN (2) | CN100402017C (de) |
AT (2) | ATE317257T1 (de) |
AU (2) | AU776301B2 (de) |
BG (3) | BG65501B1 (de) |
BR (2) | BRPI0017460B1 (de) |
CA (2) | CA2650202C (de) |
CZ (1) | CZ302628B6 (de) |
DE (2) | DE60025961T2 (de) |
DK (2) | DK1426044T3 (de) |
EA (2) | EA004459B1 (de) |
EE (2) | EE05719B1 (de) |
ES (2) | ES2258688T3 (de) |
HK (2) | HK1045145B (de) |
HR (1) | HRP20010740B1 (de) |
HU (1) | HU229366B1 (de) |
IL (4) | IL145765A0 (de) |
IS (2) | IS2476B (de) |
IT (1) | IT1306129B1 (de) |
ME (2) | ME00113B (de) |
MX (1) | MXPA01010359A (de) |
NO (2) | NO327742B1 (de) |
NZ (2) | NZ528874A (de) |
PL (2) | PL211710B1 (de) |
PT (2) | PT1183228E (de) |
RS (3) | RS20090448A (de) |
SI (2) | SI1183228T1 (de) |
SK (2) | SK287253B6 (de) |
TR (2) | TR200202358T2 (de) |
WO (1) | WO2000061543A2 (de) |
ZA (1) | ZA200109291B (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1246792B1 (de) * | 2000-01-13 | 2014-08-13 | Emisphere Technologies, Inc. | Verbindungen und zusammensetzung zur abgabe von wirkstoffen |
DE10113446A1 (de) † | 2001-03-19 | 2002-09-26 | Schwarzkopf Gmbh Hans | Haarbehandlungsmittel mit Betainen |
DK2108362T3 (da) * | 2002-06-26 | 2013-09-02 | Medigene Ag | Kationisk liposomal-fremstilling omfattende en taxan |
EP2108362B1 (de) * | 2002-06-26 | 2013-05-29 | MediGene AG | Ein kationisches Trägersystem beinhaltend Taxane |
ITRM20040288A1 (it) * | 2004-06-11 | 2004-09-11 | Sigma Tau Ind Farmaceuti | Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. |
GT200500310A (es) * | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
US20080095834A1 (en) * | 2005-03-02 | 2008-04-24 | Volkmar Weissig | Mitochondriotropic Phospholipid Vesicles |
SA06270147B1 (ar) | 2005-06-09 | 2009-12-22 | نوفارتيس ايه جي | عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين |
CN101287448A (zh) * | 2005-08-10 | 2008-10-15 | 诺瓦提斯公司 | 拓扑异构酶i的抑制剂7-叔丁氧基亚氨基甲基喜树碱的微粒组合物 |
WO2007017513A2 (en) * | 2005-08-10 | 2007-02-15 | Novartis Ag | Formulations for 7-(t-butoxy)iminomethyl camptothecin |
US20100178325A1 (en) * | 2006-08-23 | 2010-07-15 | Biodelivery Sciences International, Inc. | Amphiphilic nucleotide cochleate compositions and methods of using the same |
AU2008210511A1 (en) * | 2007-02-01 | 2008-08-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Pharmaceutical composition comprising a campothecin derivative |
US20100104625A1 (en) * | 2007-02-16 | 2010-04-29 | Cornell University | Biodegradable compositions and materials |
US20100204432A1 (en) | 2007-05-28 | 2010-08-12 | Husam Younes | Biodegradable elastomers prepared by the condensation of an organic di-, tri- or tetra-carboxylic acid and an organic diol |
ES2569660T3 (es) | 2007-06-08 | 2016-05-12 | Mannkind Corporation | Inhibidores de la IRE-1alfa |
EP2706121A1 (de) | 2008-03-13 | 2014-03-12 | PerkinElmer Health Sciences, Inc. | Enzymatische Substrat Bauelementen zum Mehrfachdetektionssysteme |
EP2532649B1 (de) * | 2011-06-07 | 2015-04-08 | Incella GmbH | Aminolipide, deren Synthese und Verwendungen davon |
WO2013032643A2 (en) * | 2011-08-31 | 2013-03-07 | Dicerna Pharmaceuticals, Inc. | Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells |
CA2906839A1 (en) | 2013-03-15 | 2014-09-18 | Perkinelmer Health Sciences, Inc. | Compounds and methods relating to testing for lysosomal storage disorders |
MX2018010586A (es) | 2016-03-02 | 2019-03-28 | Univ Texas | Nanovacuna de activacion de "sting" para inmunoterapia. |
EP3634942A4 (de) | 2017-06-06 | 2021-03-10 | Wayne State University | Verfahren und zusammensetzungen in zusammenhang mit carnitin-abgeleiteten materialien |
CN115177608B (zh) * | 2022-07-26 | 2023-12-05 | 南方医科大学南方医院 | 长链酰基肉碱类化合物在制备预防和/或治疗肝癌的药物中的应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5008288A (en) * | 1986-01-06 | 1991-04-16 | Alfred Stracher | Carnitine directed pharmaceutical agents |
US4866040A (en) * | 1986-01-06 | 1989-09-12 | Alfred Stracher | Aminocarnitine directed pharmaceutical agents |
IT1230142B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Derivati della carnitina, processo per la loro preparazione e impiego in terapia umana |
DE69119074T2 (de) * | 1990-06-15 | 1996-12-12 | University Of North Carolina At Chapel Hill, Chapel Hill, N.C. | Kovalente-ther lipidnukleosid-konjugate |
IT1248321B (it) * | 1991-05-15 | 1995-01-05 | Sigma Tau Ind Farmaceuti | Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie |
IT1258370B (it) * | 1992-03-02 | 1996-02-26 | Sigma Tau Ind Farmaceuti | Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono. |
US5972600A (en) * | 1992-04-03 | 1999-10-26 | The Regents Of The University Of California | Separation of active complexes |
IT1263013B (it) * | 1992-10-20 | 1996-07-23 | Avantgarde Spa | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. |
US5552156A (en) * | 1992-10-23 | 1996-09-03 | Ohio State University | Liposomal and micellular stabilization of camptothecin drugs |
US5512671A (en) * | 1993-02-16 | 1996-04-30 | Wake Forest University | Ether lipid-nucleoside covalent conjugates |
IT1261984B (it) * | 1993-06-22 | 1996-06-11 | Avantgarde Spa | Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
EP0706374B1 (de) * | 1993-06-30 | 1997-12-10 | Genentech, Inc. | Verfahren zur herstellung von liposomen |
IT1273987B (it) * | 1994-09-29 | 1997-07-14 | Sigma Tau Ind Farmaceuti | Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico |
US6008202A (en) * | 1995-01-23 | 1999-12-28 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
US6316652B1 (en) * | 1995-06-06 | 2001-11-13 | Kosta Steliou | Drug mitochondrial targeting agents |
AU707734B2 (en) * | 1995-06-07 | 1999-07-15 | Regents Of The University Of California, The | Stabilization of polynucleotide complexes |
US5811406A (en) * | 1995-06-07 | 1998-09-22 | Regents Of The University Of California | Dry powder formulations of polynucleotide complexes |
IT1283955B1 (it) * | 1996-03-20 | 1998-05-07 | Sigma Tau Ind Farmaceuti | Bis alcanoil esteri della carnitina ad attivita' antibatterica, antimicotica ed antiprotozoaria. |
WO1998004720A1 (en) * | 1996-07-26 | 1998-02-05 | Sloan-Kettering Institute For Cancer Research | Method and reagents for genetic immunization |
US6056973A (en) * | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
US6071532A (en) * | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
IT1299172B1 (it) * | 1998-05-06 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Esteri perfluorurati di alcanoil l-carnitine utilizzabili quali lipidi cationici per l'immissione intracellulare di composti |
-
1999
- 1999-04-13 IT IT1999RM000220A patent/IT1306129B1/it active
-
2000
- 2000-04-11 ES ES03020049T patent/ES2258688T3/es not_active Expired - Lifetime
- 2000-04-11 IL IL14576500A patent/IL145765A0/xx active IP Right Grant
- 2000-04-11 EP EP04006990A patent/EP1435232A1/de not_active Withdrawn
- 2000-04-11 RS RSP-2009/0448A patent/RS20090448A/sr unknown
- 2000-04-11 DK DK03020049T patent/DK1426044T3/da active
- 2000-04-11 SK SK1431-2001A patent/SK287253B6/sk not_active IP Right Cessation
- 2000-04-11 AU AU43123/00A patent/AU776301B2/en not_active Ceased
- 2000-04-11 SI SI200030596T patent/SI1183228T1/xx unknown
- 2000-04-11 KR KR1020067021555A patent/KR100798499B1/ko not_active IP Right Cessation
- 2000-04-11 TR TR2002/02358T patent/TR200202358T2/xx unknown
- 2000-04-11 EE EEP201100028A patent/EE05719B1/et not_active IP Right Cessation
- 2000-04-11 CN CNB2005101295985A patent/CN100402017C/zh not_active Expired - Fee Related
- 2000-04-11 SK SK5094-2008A patent/SK288246B6/sk not_active IP Right Cessation
- 2000-04-11 NZ NZ528874A patent/NZ528874A/en not_active IP Right Cessation
- 2000-04-11 PL PL386640A patent/PL211710B1/pl unknown
- 2000-04-11 ME MEP-2008-240A patent/ME00113B/me unknown
- 2000-04-11 EP EP00922852A patent/EP1183228B1/de not_active Expired - Lifetime
- 2000-04-11 PT PT00922852T patent/PT1183228E/pt unknown
- 2000-04-11 TR TR2001/02941T patent/TR200102941T2/xx unknown
- 2000-04-11 RS YUP-702/01A patent/RS50911B/sr unknown
- 2000-04-11 CZ CZ20013617A patent/CZ302628B6/cs not_active IP Right Cessation
- 2000-04-11 EA EA200101076A patent/EA004459B1/ru not_active IP Right Cessation
- 2000-04-11 EE EEP200100518A patent/EE05514B1/xx not_active IP Right Cessation
- 2000-04-11 DK DK00922852T patent/DK1183228T3/da active
- 2000-04-11 KR KR1020017013018A patent/KR100684378B1/ko not_active IP Right Cessation
- 2000-04-11 MX MXPA01010359A patent/MXPA01010359A/es active IP Right Grant
- 2000-04-11 DE DE60025961T patent/DE60025961T2/de not_active Expired - Lifetime
- 2000-04-11 JP JP2000610820A patent/JP4703855B2/ja not_active Expired - Fee Related
- 2000-04-11 NZ NZ515270A patent/NZ515270A/xx not_active IP Right Cessation
- 2000-04-11 ES ES00922852T patent/ES2234591T3/es not_active Expired - Lifetime
- 2000-04-11 RS RS20090448A patent/RS52682B/en unknown
- 2000-04-11 CN CNB008070539A patent/CN1263730C/zh not_active Expired - Fee Related
- 2000-04-11 SI SI200030799T patent/SI1426044T1/sl unknown
- 2000-04-11 BR BRPI0017460A patent/BRPI0017460B1/pt not_active IP Right Cessation
- 2000-04-11 CA CA2650202A patent/CA2650202C/en not_active Expired - Fee Related
- 2000-04-11 DE DE60017388T patent/DE60017388T2/de not_active Expired - Lifetime
- 2000-04-11 PL PL351112A patent/PL204418B1/pl unknown
- 2000-04-11 PT PT03020049T patent/PT1426044E/pt unknown
- 2000-04-11 BR BRPI0009765-9B1A patent/BR0009765B1/pt not_active IP Right Cessation
- 2000-04-11 AT AT03020049T patent/ATE317257T1/de active
- 2000-04-11 BG BG109876A patent/BG65501B1/bg unknown
- 2000-04-11 AT AT00922852T patent/ATE286873T1/de active
- 2000-04-11 EP EP03020049A patent/EP1426044B1/de not_active Expired - Lifetime
- 2000-04-11 WO PCT/IT2000/000137 patent/WO2000061543A2/en active Application Filing
- 2000-04-11 CA CA2370143A patent/CA2370143C/en not_active Expired - Fee Related
- 2000-04-11 HU HU0201446A patent/HU229366B1/hu not_active IP Right Cessation
- 2000-04-11 ME MEP-240/08A patent/MEP24008A/xx unknown
- 2000-04-11 EA EA200300745A patent/EA006021B1/ru not_active IP Right Cessation
- 2000-11-04 US US09/958,328 patent/US6797281B1/en not_active Expired - Lifetime
-
2001
- 2001-09-28 IS IS6095A patent/IS2476B/is unknown
- 2001-10-03 BG BG109876A patent/BG109876A/en unknown
- 2001-10-03 BG BG105971A patent/BG65312B1/bg unknown
- 2001-10-04 IL IL145765A patent/IL145765A/en not_active IP Right Cessation
- 2001-10-12 HR HR20010740A patent/HRP20010740B1/xx not_active IP Right Cessation
- 2001-10-12 NO NO20014985A patent/NO327742B1/no not_active IP Right Cessation
- 2001-11-12 ZA ZA200109291A patent/ZA200109291B/en unknown
-
2002
- 2002-06-12 HK HK02104388.0A patent/HK1045145B/zh not_active IP Right Cessation
-
2003
- 2003-07-23 US US10/624,645 patent/US7629003B2/en not_active Expired - Fee Related
-
2004
- 2004-01-28 US US10/765,091 patent/US20040186175A1/en not_active Abandoned
- 2004-10-29 AU AU2004224958A patent/AU2004224958B2/en not_active Ceased
-
2006
- 2006-05-01 IL IL175366A patent/IL175366A/en not_active IP Right Cessation
- 2006-12-14 HK HK06113747A patent/HK1092732A1/xx not_active IP Right Cessation
-
2007
- 2007-03-27 US US11/727,526 patent/US7585519B2/en not_active Expired - Fee Related
- 2007-08-23 IL IL185486A patent/IL185486A0/en not_active IP Right Cessation
-
2008
- 2008-03-07 IS IS8719A patent/IS2539B/is unknown
- 2008-12-30 NO NO20085413A patent/NO336949B1/no not_active IP Right Cessation
-
2010
- 2010-09-21 JP JP2010210849A patent/JP5420507B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60025961D1 (de) | Verwendung von Estern von L-Carnitinsäure oder von Alkanoyl L-Carnitinsäure als kationische Lipide für die intrazelluläre Verabreichung therapeutischer Stoffe | |
DE58905028D1 (de) | Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel. | |
KR20160040627A (ko) | 소포체 | |
GR990100388A (el) | Φαρμακευτικος συνδυασμος αποτελουμενος απο χωριστες δοσολογικες μορφες σε συσκευασια συμμορφωσης (compliance package) ενος αναστολεα της αναγωγασης του υδροξυ-μεθυλο-γλουταρυλο συνενζυμου α (στατινης, statin) και ενος παραγωγου του φιμπρικου οξεος.... | |
EP0396081A3 (de) | Verwendung von Phosphatidylcarnitin zur Herstellung von Arzneimitteln mit therapeutischer Wirkung auf mit neuronalen Schädigungen verbundenen pathologischen Zuständen beim Menschen | |
ES2135500T3 (es) | Producto farmaceutico para el tratamiento de trastornos de la piel. | |
EP0761214A3 (de) | N,N-disubstituierte Aniline oder Alkylamine als Löscher von Singulettsauerstoff; topische Zusammensetzungen, die sie enthalten | |
ATE272047T1 (de) | Perfluorierte ester von alkanoyl l-carnitin zur herstellung von kationischen lipiden zur intrazellulären verabreichung pharmakologisch aktiver verbindungen | |
ATE190837T1 (de) | Aminosäureergänzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1426044 Country of ref document: EP |